Dataset Overview

Definition:Dermoscopy Skin Lesion Imaging Datasetis provided byChangsha Langhui Information Technology Co., Ltd.The large-scale skin-disease image labelling database is built by Long Salang Langhui Information Technology. It covers skin mirror images, skin-dermal clinical photographs and standard diagnostic reports of pathological gold, maintains original resolution, oscillation/impregnation patterns and equipment information, and provides 14-dimensional structural indications of the type of skin damage (original hair/release 30+ seed type), colour, size, number, shape, ranking, edge, etc., and labels the disease term Top3 and ICD coded mapping.

Dataset NameDermoscopy Skin Lesion Imaging Dataset
Total Data Volume1,000,000 cases of skin mirrors included
Imaging ModalityDermoscope + clinical photocopy
Raw DataOriginal skin mirror images and skin-dermal clinical photographs of equipment, retention of original resolution, oscillation/impregnation mode, equipment information
Annotation Dimensions14 structured dimensions: age/part/flank type/colour/size/number/shape/arrange/wet/margin/screech, etc.
Type of skinOriginal hair loss (spectal/grape/chel/chrysal/sip/sip/sip/fung/fung) + Retardation (crum/sip/sip/sprout/ulsion, etc.) + 30 + seed type
Disease labelEach case is annotated with the TOP 3 disease diagnosis terms (including ICD-10 code mapping)
Space labelBunding Box, supporting multi-disease stoves and labelling
Source InstitutionCo-operation Sanction Section, Sanctuary Hospital
Use CasesAIS-assisted diagnosis of skin diseases, skin mirror image analysis, plaster screening, skin loss and classification

Delivery Specifications and Field Requirements

The data set strictly follows the requirements of the uniform DRM-SKIN delivery index to ensure data quality and traceability.

Delivery & Counting:One line corresponding to skin mirror examination/morbidity; multi-series/multi-view only 1 case

Coverage:Cover skin mirror images and skin-dermal clinical photographs, and maintain original resolution and equipment information

Positives and Composition:Identify the pathogen as the subject; each of the cases is benign, normal and uncertain

PathologyGold Standard:Pathologically confirmed results serve as the gold standard; suspected, considered and confirmed cases are retained separately

Cross-Data Association:Prioritize skin pathology, treatment and follow-up

2026 Frontier AI Research Progress

Domain Review:The Skin Synthetic Synthetics ACAI has made a breakthrough in multimodular integration (TG-CAVNet) and integrated learning (XGBoost+Xception AUC 0.988), with XAI interpretability and few-shot learning as the front-line direction.

Depth Learning + Integrated Learning for Blackoma Identification

Frontiers in Oncology, 2026

The XGBoost+Xception combination of AUC up to 0.988 in the Test Series, AUC 1.00 compared the performance of nine CNN models on ISIC-2024 and HAM10000.

TT-CAVNet text leading multi-modular skin pathology detection

Scientific Reports, 2026

The clinical text that integrates the Bio-ClinicalBerrt code with the EfficientNet-B4 visual features is used to achieve multi-modular detection through text-led channel characterization and cross-focus.

EfficientNetV2+XAI automatic diagnosis of skin dermal pathologies

arXiv, 2026

Based on EfficientNetV2-L+Crossion + Grad-CAM/Salitcy's Explanatory Framework, the overall accuracy rate is 91.15%, macro F1 85.45%.

Classification of dermal pathologies in small AMCANet samples

PLOS ONE

The introduction of a multiscale, multiscale, volume-based attention network to improve the few-shot classification of the skin disease in terms of the details of the local structure and boundary characteristics.

Annotation Workflow & Quality Control

1

Image Acquisition & De-identification

Standardized acquisition workflow: complete data is exported directly from the equipment, and patient identifying information (PHI) is removed before the data is stored。

2

Initial Annotation (Specialist Physician)

Attending physicians annotate case by case against the standards, including lesion localization, morphological description and disease term determination。

3

Review (Associate Chief Physician or Above)

Experts with the title of Associate Chief Physician or above review the initial annotation results item by item, correcting erroneous annotations and supplementing missing dimensions。

4

Consistency Assessment

10% of samples are randomly selected and independently annotated by 3 physicians to calculate Fleiss' Kappa; below 0.Dimensions scored 75 are flagged for rework。

License and Usage Agreement

Academic Research License

For universities and research institutions, supporting academic research related to medical AI。After signing the agreement, a de-identified data subset is provided; the source must be acknowledged:Langhui Technology DataAssetsAPI。

Commercial License

For medical device companies and AI diagnostics companies, supporting medical AI product R&D and medical device registration。Provides full datasets + custom annotation + incremental update services。

Data Compliance Statement

All images come from legally authorized sources; PHI fields are fully de-identified and contain no information that can directly identify an individual, in compliance with the Personal Information Protection Law and the Data Security Law。

Customized services

Supports extended requirements such as adding specific disease types, multimodal annotation expansion, and custom training of AI-assisted diagnostic models。

Quick Facts

Dataset CodeDERM-SKIN
Total Data Volume1 Million Cases
Imaging ModalityDermoscope + clinical photocopy
Source InstitutionPartner Grade-A Tertiary Hospitals
Quality Control StandardsKappa ≥ 0.75
Compliance & LicensingEnd-to-End Compliance

AI Frontier Research

The Skin Synthetic Synthetics ACAI has made a breakthrough in multimodular integration (TG-CAVNet) and integrated learning (XGBoost+Xception AUC 0.988), with XAI interpretability and few-shot learning as the front-line direction.

Latest 2025–2026 Papers
Nature / Nature Medicine-level Research
FDA / NMPA / CE Regulatory Updates